Fifty-six healthy male volunteers were randomly assigned to receive in double-blind and fasted conditions single oral doses of 10 , 50 , 125 , 250 , 500 , 750 , 1,000 and 1,250 mg of QGC001 ( n = 6/dose ) or placebo ( n = 2/dose ) .